The measurements of the CRP and IL-6 via the IBD AWARE device were assessed to determine its utility in the classification of individuals with active inflammation (i.e., active IBD) versus no inflammation (i.e., healthy individuals). The gene discussed is IL6; the disease is inflammatory bowel disease.